Aytu Biopharma (AYTU) Non-Current Debt (2018 - 2026)
Aytu Biopharma (AYTU) posted quarterly Non-Current Debt of $9.5 million for Q1 2026, little changed year-over-year from $9.5 million in Q1 2025, and down 4.49% quarter-over-quarter from $10.0 million in Q4 2025.
Aytu Biopharma (AYTU) Non-Current Debt (2018 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Non-Current Debt for 9 consecutive years, with $9.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt changed 0.15% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $9.5 million (changed 0.15% YoY), while the FY2025 annual figure was $10.9 million, changed 0.17% from the prior year.
- Non-Current Debt declined to $9.5 million in Q1 2026 per AYTU's latest filing, from $10.0 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $15.0 million in Q3 2022 and bottomed at $9.5 million in Q1 2025.
- Historically, Non-Current Debt has averaged $12.2 million across 5 years, with a median of $11.1 million in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Debt soared 11165.89% — and 2024, when it tumbled 33.35%.
- Aytu Biopharma's Non-Current Debt stood at $14.5 million in 2022, then advanced by 3.06% to $15.0 million in 2023, then sank by 33.35% to $10.0 million in 2024, then increased by 0.15% to $10.0 million in 2025, then fell by 4.49% to $9.5 million in 2026.
- Business Quant data shows AYTU's Non-Current Debt at $9.5 million in Q1 2026, $10.0 million in Q4 2025, and $10.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 130.00 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | 9.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.55 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.45 Mn |
| Jun 30, 2025 | 10.90 Mn |
| Mar 31, 2025 | 9.54 Mn |
| Dec 31, 2024 | 9.98 Mn |
| Sep 30, 2024 | 10.43 Mn |
| Jun 30, 2024 | 10.88 Mn |
| Dec 31, 2023 | 14.98 Mn |
| Sep 30, 2023 | 14.84 Mn |
| Jun 30, 2023 | 14.71 Mn |
| Mar 31, 2023 | 11.39 Mn |
| Dec 31, 2022 | 14.53 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 14.28 Mn |
| Mar 31, 2022 | 14.17 Mn |
| Dec 31, 2021 | 129,000.00 |
| Sep 30, 2021 | 154,000.00 |
| Jun 30, 2021 | 180,000.00 |
| Mar 19, 2021 | 15.60 Mn |